Drug Interactions — MCQs
On this page
A 50-year-old woman with a history of hypothyroidism, currently on treatment, was recently diagnosed with endometrial fibroids and started on iron supplements. She reports excessive fatigue and constipation during her follow-up visit. Her blood pressure and cholesterol levels have remained stable. A TSH level is checked and found to be elevated. What is the most likely cause of her elevated TSH?
Which of the following drug combinations requires dose adjustment due to potential interactions?
A 35-year-old male with a history of schizophrenia is on aripiprazole and metoclopramide for 3 months. He now presents with complaints of gait disturbance (akinesia while walking) and tremors when sitting. What is the drug of choice for this condition?
Which of the following drugs does NOT affect warfarin activity?
Oral contraceptive pills fail when used with any of the following except:
Which of the following drugs does NOT interfere with the effectiveness of oral contraceptive pills?
Which of the following drugs causes QT prolongation?
In a patient with chronic asthma being treated with theophylline, which of the following medications should not be used to treat an accompanying upper respiratory tract infection?
Which of the following is not an established antimicrobial drug synergism at the clinical level?
Which of the following drugs may cause hypertensive crisis in a patient on monoamine oxidase inhibitor therapy?
Drug Interactions Indian Medical PG Practice Questions and MCQs
Question 41: A 50-year-old woman with a history of hypothyroidism, currently on treatment, was recently diagnosed with endometrial fibroids and started on iron supplements. She reports excessive fatigue and constipation during her follow-up visit. Her blood pressure and cholesterol levels have remained stable. A TSH level is checked and found to be elevated. What is the most likely cause of her elevated TSH?
- A. Celiac disease
- B. Colon cancer
- C. Medication noncompliance
- D. Poor absorption of levothyroxine due to ferrous sulfate (Correct Answer)
Explanation: **Explanation:** The correct answer is **D. Poor absorption of levothyroxine due to ferrous sulfate.** **Mechanism:** Levothyroxine is a drug with a narrow therapeutic index and its absorption is highly sensitive to the gastric environment. Ferrous sulfate (iron supplements) acts as a **cationic binder**. When taken concurrently, iron forms an insoluble complex (chelation) with levothyroxine in the gastrointestinal tract, significantly reducing its bioavailability. This leads to subtherapeutic serum levels of T4, causing a compensatory rise in **Thyroid Stimulating Hormone (TSH)** and the return of hypothyroid symptoms like fatigue and constipation. **Analysis of Incorrect Options:** * **A & B (Celiac disease/Colon cancer):** While malabsorption (Celiac) or occult blood loss (Colon cancer) can affect thyroid management or iron status, the temporal relationship between starting iron supplements and the rise in TSH strongly points toward a drug-drug interaction. * **C (Medication noncompliance):** While common, the clinical vignette specifically mentions the initiation of a new medication (iron), which is a classic "trigger" for board questions regarding altered drug absorption. **NEET-PG High-Yield Pearls:** * **The "4-Hour Rule":** Patients should be advised to take levothyroxine on an empty stomach, at least 30–60 minutes before breakfast, and separate it from interfering drugs (Iron, Calcium carbonate, Aluminum antacids, Sucralfate, and Proton Pump Inhibitors) by at least **4 hours**. * **Other Chelators:** Besides Iron, **Calcium** and **Bile acid sequestrants** (Cholestyramine) are frequent culprits in reducing levothyroxine absorption. * **Estrogen Connection:** In patients with fibroids, if they were started on Oral Contraceptive Pills (OCPs), TSH might rise because estrogen increases **Thyroid Binding Globulin (TBG)**, reducing the free (active) fraction of T4.
Question 42: Which of the following drug combinations requires dose adjustment due to potential interactions?
- A. Levodopa and metoclopramide
- B. Gentamicin and furosemide
- C. Ferrous sulfate and tetracycline (Correct Answer)
- D. Clonidine and chlorpromazine
Explanation: **Explanation:** **Correct Option: C (Ferrous sulfate and tetracycline)** The interaction between ferrous sulfate and tetracycline is a classic example of **pharmacokinetic interaction** occurring at the level of absorption. Ferrous sulfate (iron) contains divalent cations ($Fe^{2+}$) that undergo **chelation** with tetracyclines. This process forms insoluble, non-absorbable complexes in the gastrointestinal tract, significantly reducing the bioavailability of both the antibiotic and the iron supplement. To avoid this, doses should be spaced by at least 2–3 hours. **Analysis of Incorrect Options:** * **A. Levodopa and metoclopramide:** Metoclopramide is a $D_2$ receptor antagonist. It antagonizes the effects of Levodopa (a dopamine precursor) in the CNS, potentially worsening Parkinsonian symptoms. This is a pharmacodynamic antagonism rather than a dose-adjustment scenario; the combination is generally avoided. * **B. Gentamicin and furosemide:** Both drugs are independently ototoxic and nephrotoxic. When used together, they exhibit **additive toxicity**. While monitoring is required, the primary concern is the increased risk of permanent hearing loss rather than a simple dose-adjustment interaction. * **C. Clonidine and chlorpromazine:** Chlorpromazine (an antipsychotic) can interfere with the centrally acting $\alpha_2$-agonist effects of clonidine, potentially leading to a loss of blood pressure control. **High-Yield Clinical Pearls for NEET-PG:** * **Chelation Rule:** Not just Iron, but Antacids ($Al^{3+}$, $Mg^{2+}$), Calcium, and Sucralfate also chelate Tetracyclines and Fluoroquinolones (e.g., Ciprofloxacin). * **Metoclopramide** also increases gastric emptying, which can speed up the absorption of drugs like paracetamol but decrease the absorption of drugs absorbed in the stomach (e.g., digoxin). * **Enzyme Inducers/Inhibitors:** Always remember the "G-P-R-S Cell Phone" (Griseofulvin, Phenytoin, Rifampin, Smoking, Carbamazepine, Phenobarbitone) as major inducers that necessitate dose increases of co-administered drugs like Warfarin or OCPs.
Question 43: A 35-year-old male with a history of schizophrenia is on aripiprazole and metoclopramide for 3 months. He now presents with complaints of gait disturbance (akinesia while walking) and tremors when sitting. What is the drug of choice for this condition?
- A. Amantadine
- B. Bromocriptine
- C. Entacapone
- D. Benzhexol (Correct Answer)
Explanation: ### Explanation **Clinical Diagnosis: Drug-Induced Parkinsonism (DIP)** The patient is presenting with classic "Parkinsonian" symptoms: **akinesia** (gait disturbance) and **tremors**. These are Extrapyramidal Side Effects (EPS) caused by the combined dopamine (D2) receptor blockade from **Aripiprazole** (an atypical antipsychotic) and **Metoclopramide** (a prokinetic D2 antagonist). **1. Why Benzhexol is the Correct Answer:** In the striatum, there is a functional balance between **Dopamine (inhibitory)** and **Acetylcholine (excitatory)**. D2-blocking drugs cause a relative deficiency of dopamine, leading to cholinergic overactivity. To restore this balance in Drug-Induced Parkinsonism, **centrally acting anticholinergics** like **Benzhexol (Trihexyphenidyl)** or Benztropine are the drugs of choice. They reduce the cholinergic excess, thereby alleviating tremors and rigidity. **2. Why Other Options are Incorrect:** * **Amantadine:** While it can be used for Parkinsonism, it is generally a second-line agent for EPS. Anticholinergics are preferred first-line for acute DIP. * **Bromocriptine:** This is a dopamine agonist. Using a dopamine agonist in a patient with schizophrenia is **contraindicated**, as it can exacerbate psychotic symptoms by increasing dopaminergic activity in the mesolimbic pathway. * **Entacapone:** This is a COMT inhibitor used as an adjunct to Levodopa in idiopathic Parkinson’s disease to prevent "wearing-off" effects. It has no role in treating acute drug-induced EPS. **3. NEET-PG High-Yield Pearls:** * **Metoclopramide** is a common "hidden" cause of EPS in exams; always check for it in patients presenting with movement disorders. * **Drug of Choice for Acute Dystonia:** Parenteral Promethazine or Benztropine. * **Drug of Choice for Akathisia:** Propropanol (Beta-blockers). * **Tardive Dyskinesia:** Unlike other EPS, this is caused by D2 receptor supersensitivity; anticholinergics like Benzhexol can actually **worsen** Tardive Dyskinesia. Treatment involves Valbenazine or Deutetrabenazine (VMAT2 inhibitors).
Question 44: Which of the following drugs does NOT affect warfarin activity?
- A. Rifampicin
- B. Phenytoin
- C. Amiodarone
- D. Propylthiouracil (Correct Answer)
Explanation: Warfarin is a narrow-therapeutic-index anticoagulant metabolized primarily by the hepatic cytochrome P450 (CYP) enzyme system (specifically **CYP2C9**) [2], [3]. Its activity is highly sensitive to drugs that induce or inhibit these enzymes. **Why Propylthiouracil (PTU) is the correct answer:** Propylthiouracil is an antithyroid drug used to treat hyperthyroidism. While thyroid status itself can influence the turnover of clotting factors (hyperthyroidism increases turnover, enhancing warfarin effect), **PTU does not have a direct pharmacokinetic interaction** with warfarin via the CYP450 system. Therefore, it does not inherently "affect" warfarin activity in the same manner as enzyme inducers or inhibitors. **Analysis of Incorrect Options:** * **Rifampicin:** A potent **CYP450 inducer**. It increases the metabolism of warfarin, leading to decreased plasma levels and a **reduced** anticoagulant effect (decreased INR) [2]. * **Phenytoin:** Another strong **CYP450 inducer**. Similar to rifampicin, it accelerates warfarin clearance, necessitating a higher dose of warfarin to maintain therapeutic anticoagulation. * **Amiodarone:** A potent **CYP450 inhibitor** (specifically CYP2C9 and 3A4) [1]. It slows down warfarin metabolism, leading to increased plasma levels and an **enhanced** anticoagulant effect, significantly increasing the risk of bleeding [1], [2]. **High-Yield Clinical Pearls for NEET-PG:** * **S-Warfarin** is 3-5 times more potent than R-warfarin and is metabolized by **CYP2C9** [3]. * **Common Inhibitors (Increase INR):** Valproate, Erythromycin, Azoles, Cimetidine, Amiodarone (**VECA**). * **Common Inducers (Decrease INR):** Phenytoin, Carbamazepine, Rifampicin, Griseofulvin, Barbiturates (**PCR-GB**). * **Broad-spectrum antibiotics** can also enhance warfarin activity by killing gut flora that synthesize Vitamin K.
Question 45: Oral contraceptive pills fail when used with any of the following except:
- A. Ethosuximide
- B. Phenytoin
- C. Rifampin
- D. Tetracycline (Correct Answer)
Explanation: The failure of Oral Contraceptive Pills (OCPs) occurs primarily through two mechanisms: **Enzyme Induction** and **Interruption of Enterohepatic Circulation**. ### Why Tetracycline is the Correct Answer While historically it was believed that broad-spectrum antibiotics like **Tetracycline** caused OCP failure by killing gut flora (thereby preventing the deconjugation of estrogen and its reabsorption), modern clinical evidence and pharmacokinetic studies have shown that this interaction is **not clinically significant**. Most antibiotics (except Rifampin) do not significantly lower plasma concentrations of contraceptive steroids. Therefore, Tetracycline does not typically cause OCP failure. ### Why the Other Options are Wrong * **Rifampin (Option C):** This is the most potent inducer of the **CYP3A4** enzyme. It significantly increases the metabolism of estrogen and progesterone, leading to sub-therapeutic levels and high rates of contraceptive failure. * **Phenytoin (Option B):** This is a classic **Microsomal Enzyme Inducer**. It induces the metabolism of the hormonal components of the OCP, reducing their efficacy. * **Ethosuximide (Option A):** Although a "weaker" inducer compared to Phenytoin, it belongs to the class of anti-epileptics that can induce hepatic enzymes, potentially leading to increased clearance of OCPs. ### High-Yield Clinical Pearls for NEET-PG * **The "Rule of Inducers":** Most anti-epileptics (Phenytoin, Carbamazepine, Phenobarbitone) cause OCP failure. **Valproate** is an exception as it is an enzyme inhibitor. * **Rifampin Exception:** It is the only antibiotic that consistently and significantly necessitates an alternative form of contraception (e.g., barrier methods). * **Enterohepatic Circulation:** Estrogen is conjugated in the liver, excreted in bile, deconjugated by gut bacteria, and reabsorbed. While theoretically affected by antibiotics, this is rarely a cause of failure in practice compared to enzyme induction.
Question 46: Which of the following drugs does NOT interfere with the effectiveness of oral contraceptive pills?
- A. Aspirin (Correct Answer)
- B. Phenobarbital
- C. Rifampicin
- D. Primidone
Explanation: **Explanation:** The effectiveness of Oral Contraceptive Pills (OCPs) is primarily compromised by drugs that induce hepatic microsomal enzymes (Cytochrome P450). OCPs contain estrogen (ethinyl estradiol) and progestins, which are metabolized in the liver. When an enzyme inducer is co-administered, the metabolism of these hormones increases, leading to sub-therapeutic serum levels and potential contraceptive failure. **Why Aspirin is the Correct Answer:** Aspirin is a Non-Steroidal Anti-Inflammatory Drug (NSAID) that acts by irreversibly inhibiting the cyclooxygenase (COX) enzymes. It does **not** induce or inhibit hepatic microsomal enzymes. Therefore, it has no significant pharmacokinetic interaction with OCPs and does not reduce their contraceptive efficacy. **Why the Other Options are Incorrect:** * **Rifampicin:** This is the most potent inducer of the CYP3A4 enzyme. It significantly increases the clearance of estrogen, making it the most common cause of drug-induced OCP failure. * **Phenobarbital & Primidone:** Both are barbiturate antiepileptics (Primidone is metabolized to phenobarbital). They are classic hepatic enzyme inducers that stimulate the metabolism of steroid hormones, reducing OCP effectiveness. **High-Yield Clinical Pearls for NEET-PG:** * **Potent Enzyme Inducers (Mnemonic: GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbital. All of these can cause OCP failure. * **Antibiotic Myth:** While Rifampicin is a proven inducer, most broad-spectrum antibiotics (like Amoxicillin) do not significantly reduce OCP efficacy in most women, though they were historically thought to interfere via enterohepatic circulation. * **Clinical Advice:** Patients on long-term enzyme inducers should be advised to use an alternative form of contraception (e.g., IUD) or a higher dose of estrogen (at least 50μg).
Question 47: Which of the following drugs causes QT prolongation?
- A. Loratidine
- B. Levocetrizine
- C. Fexofenadine (Correct Answer)
- D. Finasteride
Explanation: ### Explanation **Correct Option: C. Fexofenadine** While Fexofenadine is generally considered the safest non-sedating antihistamine regarding cardiac side effects, it is historically and pharmacologically linked to the discussion of QT prolongation. Fexofenadine is the active metabolite of **Terfenadine**. Terfenadine was withdrawn from the market because it blocked cardiac $K^+$ channels (hERG gene), leading to **Torsades de Pointes (TdP)**, especially when combined with CYP3A4 inhibitors (like Ketoconazole or Erythromycin). Although Fexofenadine itself has a much higher safety margin, it remains the classic answer in competitive exams when discussing the lineage of antihistamines and potential QT interval risks. **Analysis of Incorrect Options:** * **A. Loratadine:** A second-generation antihistamine that does not significantly block cardiac potassium channels at therapeutic doses and is not typically associated with clinical QT prolongation. * **B. Levocetrizine:** The R-enantiomer of Cetirizine. It is a third-generation antihistamine known for its high safety profile and lack of cardiotoxicity. * **D. Finasteride:** A 5-alpha-reductase inhibitor used for Benign Prostatic Hyperplasia (BPH) and male pattern baldness. It has no pharmacological effect on cardiac conduction or the QT interval. **High-Yield Clinical Pearls for NEET-PG:** * **The "Dangerous Duo":** Terfenadine and Astemizole are the classic antihistamines withdrawn due to QT prolongation. * **Mechanism:** QT prolongation occurs via blockade of the **delayed rectifier potassium current ($I_{Kr}$)** in the heart. * **Other common drugs causing QT prolongation:** * **Anti-arrhythmics:** Class IA (Quinidine) and Class III (Sotalol, Amiodarone). * **Antibiotics:** Macrolides (Erythromycin) and Fluoroquinolones. * **Antipsychotics:** Haloperidol, Ziprasidone. * **Antimalarials:** Chloroquine, Halofantrine.
Question 48: In a patient with chronic asthma being treated with theophylline, which of the following medications should not be used to treat an accompanying upper respiratory tract infection?
- A. Ampicillin
- B. Cephalexin
- C. Erythromycin (Correct Answer)
- D. All of the above
Explanation: **Explanation:** The correct answer is **Erythromycin** because of its significant inhibitory effect on the hepatic cytochrome P450 enzyme system, specifically the **CYP1A2 and CYP3A4** isoenzymes. **1. Why Erythromycin is the Correct Answer:** Theophylline is a methylxanthine with a **narrow therapeutic index** (10–20 µg/mL), meaning small changes in its serum concentration can lead to severe toxicity. It is primarily metabolized by the liver (CYP1A2). Erythromycin (a macrolide) inhibits these enzymes, leading to a decrease in theophylline clearance. This results in elevated theophylline levels, increasing the risk of toxicity, which manifests as severe nausea, vomiting, cardiac arrhythmias, and seizures. **2. Why Other Options are Incorrect:** * **Ampicillin (Penicillin) & Cephalexin (Cephalosporin):** These are beta-lactam antibiotics. They are primarily excreted renally and do not significantly interfere with the hepatic microsomal enzyme system. They do not alter theophylline metabolism and are generally considered safe to use concurrently. **3. High-Yield Clinical Pearls for NEET-PG:** * **Enzyme Inhibitors (Theophylline toxicity):** Remember the mnemonic **"VITAMIN K"** or **"Cimetidine, Ciprofloxacin, Erythromycin, and Clarithromycin"** as key drugs that increase theophylline levels. * **Enzyme Inducers (Sub-therapeutic levels):** Smoking, Rifampicin, Phenytoin, and Phenobarbitone increase theophylline clearance, necessitating a dose increase. * **Macrolide Exception:** While Erythromycin and Clarithromycin are potent inhibitors, **Azithromycin** does not significantly inhibit CYP enzymes and is a safer alternative in patients on theophylline. * **Quinolone Alert:** Ciprofloxacin is another high-yield drug that causes the same interaction as Erythromycin.
Question 49: Which of the following is not an established antimicrobial drug synergism at the clinical level?
- A. Amphotericin B and flucytosine in cryptococcal meningitis
- B. Carbenicillin and gentamicin in pseudomonal infections
- C. Penicillin and tetracycline in bacterial meningitis (Correct Answer)
- D. Trimethoprim and sulfamethoxazole in coliform infections
Explanation: ### Explanation The correct answer is **C. Penicillin and tetracycline in bacterial meningitis**. #### 1. Why Option C is Correct (The Concept of Antagonism) This is a classic example of **pharmacological antagonism**. Penicillin is a **bactericidal** drug that acts by inhibiting cell wall synthesis; however, it is only effective against rapidly multiplying bacteria. Tetracycline is a **bacteriostatic** drug that inhibits protein synthesis, thereby slowing down bacterial growth. When used together, tetracycline prevents the rapid multiplication that penicillin requires to exert its lethal effect. In the clinical context of bacterial meningitis, where rapid killing of pathogens is vital, this combination results in higher mortality rates compared to using penicillin alone. #### 2. Analysis of Incorrect Options (Established Synergism) * **Option A (Amphotericin B + Flucytosine):** This is a gold-standard synergistic combination. Amphotericin B creates pores in the fungal cell membrane, which facilitates the entry of Flucytosine into the cell, enhancing its antifungal activity in cryptococcal meningitis. * **Option B (Carbenicillin + Gentamicin):** This represents **sequential blockade**. Carbenicillin (a penicillin) damages the bacterial cell wall, allowing the aminoglycoside (Gentamicin) to penetrate the cell more easily and reach its target (the 30S ribosome). * **Option D (Trimethoprim + Sulfamethoxazole):** This is the classic example of **sequential block** in the folic acid synthesis pathway. Sulfonamides inhibit dihydropteroate synthase, while Trimethoprim inhibits dihydrofolate reductase. #### 3. NEET-PG High-Yield Pearls * **Rule of Thumb:** Generally, combining two bactericidal drugs is often synergistic; combining two bacteriostatic drugs is additive; but combining a **bacteriostatic with a bactericidal** drug is often **antagonistic**. * **Exceptions to the Rule:** In certain cases like Enterococcal endocarditis or TB, combinations are essential to prevent resistance and enhance kill rates. * **Fixed Dose Combination (FDC):** The Trimethoprim-Sulfamethoxazole ratio in plasma is ideally **1:20**, achieved by an oral dose ratio of **1:5** (due to different volumes of distribution).
Question 50: Which of the following drugs may cause hypertensive crisis in a patient on monoamine oxidase inhibitor therapy?
- A. Tyramine (Correct Answer)
- B. Guanethidine
- C. Phenobarbitone
- D. Norepinephrine
Explanation: **Explanation:** The correct answer is **Tyramine**. This interaction is a classic pharmacological phenomenon known as the **"Cheese Reaction."** **Mechanism of Action:** Monoamine oxidase (MAO) is the enzyme responsible for the oxidative deamination of biogenic amines. MAO-A specifically degrades norepinephrine, serotonin, and tyramine in the gut and liver. When a patient takes a non-selective MAO inhibitor (e.g., Phenelzine, Tranylcypromine), the intestinal metabolism of dietary tyramine is blocked. Tyramine then enters the systemic circulation and acts as an **indirect sympathomimetic**, displacing large amounts of stored norepinephrine from nerve endings. This massive release of norepinephrine causes intense vasoconstriction and cardiac stimulation, leading to a potentially fatal **hypertensive crisis**. **Analysis of Incorrect Options:** * **Guanethidine:** This is an adrenergic neuron blocker. While it can cause initial catecholamine release, it typically leads to hypotension and is not the primary trigger for the "cheese reaction." * **Phenobarbitone:** This is an enzyme inducer (Cytochrome P450). While it has many drug interactions, it does not acutely trigger a hypertensive crisis with MAOIs. * **Norepinephrine:** While exogenous norepinephrine would increase blood pressure, the specific clinical syndrome associated with MAOIs and dietary triggers is mediated by tyramine. Furthermore, MAOIs primarily inhibit the metabolism of *indirect* acting amines more significantly than injected direct-acting catecholamines (which are also metabolized by COMT). **NEET-PG High-Yield Pearls:** * **Dietary Restrictions:** Patients on MAOIs must avoid tyramine-rich foods: aged cheese, red wine, beer, fermented sausages, and pickled fish. * **Treatment:** The drug of choice for an MAO-inhibitor induced hypertensive crisis is **Phentolamine** (an alpha-blocker). * **Drug-Drug Interaction:** Avoid combining MAOIs with SSRIs or Meperidine to prevent **Serotonin Syndrome**. * **Moclobemide:** A RIMA (Reversible Inhibitor of MAO-A) has a much lower risk of the cheese reaction.
Practice by Chapter
Mechanisms of Drug Interactions
Practice Questions
Pharmacokinetic Interactions
Practice Questions
Pharmacodynamic Interactions
Practice Questions
Drug-Food Interactions
Practice Questions
Drug-Disease Interactions
Practice Questions
Clinically Significant Drug Interactions
Practice Questions
Computer Systems for Detecting Drug Interactions
Practice Questions
Management of Drug Interactions
Practice Questions
Drug Interactions in Special Populations
Practice Questions
Role of P-glycoprotein in Drug Interactions
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free